MoneyWorks4Me

Novelix Pharmaceuticals informs about board meeting

21 Jun 2025 Evaluate
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Novelix Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 24th June, 2025 at the Registered office of the Company, to discuss the following: 1. To consider and approve the conversion of Warrants into Equity Shares of the Company; 2. Any other matter with the permission of chair. 

The above information is a part of company’s filings submitted to BSE.

Novelix Pharma Share Price

76.90 2.93 (3.96%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 333.55
Amrapali Industries 36.65
Adani Enterprises 3040.00
Rashi Peripheral 834.10
PDS 371.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: